NextPharma Edinburgh site is a centre of excellence for development and manufacture of liquid filled hard capsule products.

The Edinburgh facility is one of the world's largest dedicated sites for the development and manufacture of liquid and semi-solid pharmaceuticals using liquid-filled hard capsule technology (LFHC). The site is fully integrated and supports all aspects of development, scale-up and manufacture of LFHC products. The team in Edinburgh has over 30 years’ experience in developing and commercializing innovative products using LFHC technology. The site was acquired from Lonza in 2021. 

The following services are offered

Pharmaceutical Development

  • Pharmaceutical formulation development
  • Scale-up (pilot-scale, production-scale)
  • Technical transfer
  • Validation
  • Manufacturing of stability batches including registration and validation
  • Galenic optimisation of existing formulation


  • Analytical development
  • Validation
  • Stability testing
  • Quality control including in-house microbiology testing
  • Market release

Clinical and Commercial Manufacturing & Packaging Capacity

API size reduction Impact milling
Bulk mix preparation 20L, 200L and 400L vessels
Capsule filling and banding Bench to commercial scale, up to 100k capsules/hour
Drum coating Multiple scales, up to 120k capsules/batch
Capsule printing Off-set roller printing, up to 80k capsules/hour
Blister packing and cartoning Thermoform capability with full lid foil printing
Serialisation Level 4 system with tamper evident closure
Containment High containment API handling in dedicated suites
Manufacturing 900 m² total (400 m2 dedicated to HP production)
Regulatory status MHRA approved and FDA inspected

Site contact information


Unit 1-8 Oakbank Parkway

Scotland EH53 0TH